or Try an Advanced Search...

    Host Disease Stocks List

    Symbol Grade Name % Change
    MESO B Mesoblast Limited -1.94
    JAZZ B Jazz Pharmaceuticals plc 2.21
    EBS C Emergent Biosolutions, Inc. 2.20
    PLUR D Pluri Inc. -1.38
    OCGN F Ocugen, Inc. 0.98
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Graft Versus Host Disease Biotechnology Transplantation Bone Drugs Life Sciences Medicine Monoclonal Antibody Rheumatoid Arthritis Stem Cell Acute Lymphoblastic Leukemia Acute Respiratory Distress Syndrome Adult Stem Cell Anthrax Anthrax Vaccines Antibiotics Asparaginase Back Pain Biodefense Biological Warfare

    Related ETFs - A few ETFs which own one or more of the above listed Host Disease stocks.

    Symbol Grade Name Weight
    XPH B SPDR S&P Pharmaceuticals ETF 3.94
    YOLO F AdvisorShares Pure Cannabis ETF 3.63
    PJP D PowerShares Dynamic Pharmaceuticals 3.62
    FTXH D First Trust Nasdaq Pharmaceuticals ETF 3.45
    TOKE F Cambria Cannabis ETF 3.4
    View all Host Disease ETFs...
    Compare ETFs
    Compare PJP to FTXH Compare XPH to YOLO Compare YOLO to PJP

        Host Disease Stocks Recent News

        Date Stock Title
        Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
        Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
        Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
        Nov 20 OCGN Ocugen Announces European Medicines Agency Grants Orphan Medicinal Product Designation for Modifier Gene Therapy Candidate OCU410ST for Treatment of ABCA4-Associated Retinopathies including Stargardt Disease
        Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
        Nov 19 OCGN Ocugen reports positive data for OCU400, OCU410
        Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
        Nov 19 JAZZ Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
        Nov 19 OCGN Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
        Nov 18 JAZZ Jazz Pharmaceuticals: High Uncertainty, Low Risk
        Nov 18 JAZZ Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?
        Nov 17 EBS First mpox case linked to African outbreak reported in U.S.
        Nov 15 EBS Vaccine stocks drop on concerns about RFK Jr. heading HHS (update)
        Nov 15 PLUR Pluri First Quarter 2025 Earnings: US$1.08 loss per share (vs US$0.96 loss in 1Q 2024)
        Nov 14 EBS Vaccine makers close lower amid reports RFK Jr may head HHS (update)
        Nov 14 OCGN Ocugen (OCGN) Reports Q3 Loss, Misses Revenue Estimates
        Nov 14 OCGN Ocugen: Q3 Earnings Snapshot
        Related Industries: Biotechnology
        Related Stock Lists: Graft Versus Host Disease Biotechnology Transplantation Bone Drugs Life Sciences Medicine Monoclonal Antibody Rheumatoid Arthritis Stem Cell Acute Lymphoblastic Leukemia Acute Respiratory Distress Syndrome Adult Stem Cell Anthrax Anthrax Vaccines Antibiotics Asparaginase Back Pain Biodefense Biological Warfare
        Host Disease

        Host disease is a condition in which the body's immune system attacks its own cells and tissues. It is also known as autoimmune disease or autoimmunity. Host disease can affect any part of the body, including the skin, joints, muscles, and organs. Symptoms vary depending on the type of host disease, but can include fatigue, joint pain, skin rashes, and organ damage.

        Browse All Tags